Contact

New Peptide Tools to Study Immune Checkpoint Inhibitors

We are happy to announce the launch of new PepMixes™ and RepliTopes™ representing validated immune checkpoint inhibitors. Immune checkpoint inhibitors are important targets for immunotherapy in multiple cancer types.

PepMix™ Human (hPD-1)
Pool of 70 peptides for hPD-1 for antigen specific stimulation of T cells

PepMix™ Human (PD-L1)
Pool of 70 peptides for PD-L1 for antigen specific stimulation of T cells

PepMix™ Human (CTLA4)
Pool of 53 peptides for CTLA4 for antigen specific stimulation of T cells

RepliTope™ Antigen Collection Immuno Checkpoints Ultra
Covers 8 different immuno checkpoint proteins with various amino acid substitutions (665 peptides)

Multiwell RepliTope™ PD-L1 Ultra
Displays a scan through PD-L1 in 21 subarrays for incubation with 20 samples (+ control) in parallel

We welcome and invite your comments and questions!

Stay in touch and be the first to receive the latest news!